Literature DB >> 22565961

Biotech's wellspring: a survey of the health of the private sector.

Brady Huggett1.   

Abstract

Mesh:

Year:  2012        PMID: 22565961     DOI: 10.1038/nbt.2209

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  2 in total

1.  Amgen spikes interest in live virus vaccines for hard-to-treat cancers.

Authors:  Charlie Schmidt
Journal:  Nat Biotechnol       Date:  2011-04       Impact factor: 54.908

2.  In defense of life sciences venture investing.

Authors:  Bruce L Booth; Bijan Salehizadeh
Journal:  Nat Biotechnol       Date:  2011-07-11       Impact factor: 54.908

  2 in total
  8 in total

1.  Publications and patents in corporate venture-backed biotech.

Authors:  Elisa Alvarez-Garrido; Gary Dushnitsky
Journal:  Nat Biotechnol       Date:  2013-06       Impact factor: 54.908

2.  Commercializing biomedical research through securitization techniques.

Authors:  Jose-Maria Fernandez; Roger M Stein; Andrew W Lo
Journal:  Nat Biotechnol       Date:  2012-10       Impact factor: 54.908

3.  Social networks attempt to spark academic-university collaborations.

Authors:  Arlene Weintraub
Journal:  Nat Biotechnol       Date:  2012-10       Impact factor: 54.908

4.  Nonprofit foundations for open-source biomedical technology development.

Authors:  John V Frangioni
Journal:  Nat Biotechnol       Date:  2012-10       Impact factor: 54.908

5.  The changing face of corporate venturing in biotechnology.

Authors:  Georg von Krogh; Boris Battistini; Fotini Pachidou; Pius Baschera
Journal:  Nat Biotechnol       Date:  2012-10       Impact factor: 54.908

6.  Investors boost Canadian startups but public sector underperforms.

Authors:  Emily Waltz
Journal:  Nat Biotechnol       Date:  2012-08       Impact factor: 54.908

7.  Can biotech spur job creation?

Authors: 
Journal:  Nat Biotechnol       Date:  2012-08       Impact factor: 54.908

8.  Biotech's wellspring: the health of private biotech in 2012.

Authors:  Brady Huggett
Journal:  Nat Biotechnol       Date:  2013-05       Impact factor: 54.908

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.